Sally Stabler
Concepts (819)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitamin B 12 Deficiency | 62 | 2020 | 78 | 7.220 |
Why?
| Vitamin B 12 | 60 | 2020 | 122 | 6.200 |
Why?
| Homocysteine | 79 | 2024 | 149 | 5.550 |
Why?
| Homocystinuria | 18 | 2024 | 69 | 3.910 |
Why?
| Folic Acid | 52 | 2024 | 184 | 3.360 |
Why?
| Methionine | 40 | 2021 | 157 | 3.210 |
Why?
| Methylmalonic Acid | 54 | 2017 | 62 | 3.100 |
Why?
| Folic Acid Deficiency | 27 | 2021 | 48 | 2.860 |
Why?
| Cystathionine beta-Synthase | 17 | 2024 | 68 | 2.280 |
Why?
| Liver | 29 | 2024 | 1826 | 2.200 |
Why?
| Betaine | 19 | 2024 | 72 | 2.050 |
Why?
| S-Adenosylmethionine | 22 | 2020 | 52 | 1.860 |
Why?
| S-Adenosylhomocysteine | 17 | 2020 | 21 | 1.840 |
Why?
| Hyperhomocysteinemia | 14 | 2020 | 26 | 1.700 |
Why?
| Vitamin B Complex | 10 | 2020 | 41 | 1.620 |
Why?
| Amino Acids, Sulfur | 4 | 2020 | 7 | 1.460 |
Why?
| Nutritional Status | 8 | 2020 | 325 | 1.110 |
Why?
| Cysteine | 12 | 2020 | 186 | 1.100 |
Why?
| Betaine-Homocysteine S-Methyltransferase | 3 | 2019 | 11 | 1.020 |
Why?
| Taurine | 4 | 2019 | 40 | 1.020 |
Why?
| Tetrahydrofolates | 2 | 2024 | 18 | 0.990 |
Why?
| Tetrahydrofolate Dehydrogenase | 1 | 2024 | 22 | 0.910 |
Why?
| Sulfur | 3 | 2020 | 50 | 0.820 |
Why?
| Oxidation-Reduction | 5 | 2024 | 1001 | 0.780 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 9 | 2021 | 34 | 0.780 |
Why?
| Choline | 11 | 2017 | 119 | 0.750 |
Why?
| Dietary Supplements | 15 | 2020 | 531 | 0.740 |
Why?
| Sulfur Compounds | 1 | 2020 | 6 | 0.710 |
Why?
| Methionine Adenosyltransferase | 6 | 2020 | 9 | 0.710 |
Why?
| Anemia | 6 | 2014 | 160 | 0.650 |
Why?
| Metabolic Diseases | 1 | 2020 | 105 | 0.640 |
Why?
| Glycine Hydroxymethyltransferase | 6 | 2021 | 16 | 0.570 |
Why?
| Anemia, Megaloblastic | 6 | 2020 | 8 | 0.540 |
Why?
| Methylation | 12 | 2020 | 227 | 0.530 |
Why?
| Cystathionine | 14 | 2012 | 24 | 0.520 |
Why?
| Animals | 66 | 2024 | 34479 | 0.510 |
Why?
| Diet | 12 | 2013 | 1199 | 0.500 |
Why?
| Humans | 162 | 2021 | 128418 | 0.500 |
Why?
| Female | 118 | 2024 | 68154 | 0.480 |
Why?
| Aged, 80 and over | 34 | 2017 | 7033 | 0.470 |
Why?
| Iron, Dietary | 1 | 2014 | 21 | 0.460 |
Why?
| Anemia, Iron-Deficiency | 2 | 2014 | 57 | 0.460 |
Why?
| Adenosylhomocysteinase | 5 | 2021 | 10 | 0.450 |
Why?
| Mice | 34 | 2024 | 16602 | 0.440 |
Why?
| Heterogeneous-Nuclear Ribonucleoproteins | 4 | 2017 | 18 | 0.440 |
Why?
| Amino Acid Metabolism, Inborn Errors | 4 | 2015 | 22 | 0.440 |
Why?
| Gas Chromatography-Mass Spectrometry | 16 | 2020 | 126 | 0.430 |
Why?
| Glutathione | 8 | 2020 | 334 | 0.430 |
Why?
| Male | 102 | 2024 | 62858 | 0.420 |
Why?
| Disease Models, Animal | 15 | 2021 | 3937 | 0.400 |
Why?
| Cognition Disorders | 5 | 2011 | 497 | 0.390 |
Why?
| Neural Tube Defects | 4 | 2020 | 63 | 0.380 |
Why?
| Aged | 59 | 2017 | 21953 | 0.380 |
Why?
| Dose-Response Relationship, Drug | 11 | 2020 | 1936 | 0.360 |
Why?
| Phosphatidylethanolamine N-Methyltransferase | 4 | 2017 | 8 | 0.360 |
Why?
| Biomarkers | 19 | 2020 | 3880 | 0.360 |
Why?
| Isoenzymes | 5 | 2012 | 304 | 0.350 |
Why?
| Frail Elderly | 2 | 2010 | 121 | 0.350 |
Why?
| Metabolism, Inborn Errors | 5 | 2020 | 40 | 0.340 |
Why?
| Hydrogen Sulfide | 2 | 2020 | 42 | 0.340 |
Why?
| Receptors, Cell Surface | 3 | 2015 | 371 | 0.340 |
Why?
| Methylmalonyl-CoA Mutase | 9 | 2017 | 10 | 0.340 |
Why?
| Uracil | 4 | 2021 | 30 | 0.340 |
Why?
| Carbon | 3 | 2024 | 207 | 0.330 |
Why?
| Thrombosis | 2 | 2011 | 324 | 0.330 |
Why?
| Cystathionine gamma-Lyase | 4 | 2020 | 12 | 0.330 |
Why?
| Middle Aged | 57 | 2020 | 30889 | 0.330 |
Why?
| Thioctic Acid | 1 | 2009 | 7 | 0.330 |
Why?
| Adult | 69 | 2020 | 35300 | 0.320 |
Why?
| Abortion, Spontaneous | 1 | 2009 | 99 | 0.320 |
Why?
| Intestinal Absorption | 3 | 2013 | 96 | 0.300 |
Why?
| Vitamin B Deficiency | 1 | 2008 | 1 | 0.300 |
Why?
| Propionibacterium | 1 | 2008 | 2 | 0.300 |
Why?
| Eubacterium | 1 | 2008 | 3 | 0.300 |
Why?
| DNA | 8 | 2020 | 1390 | 0.300 |
Why?
| Up-Regulation | 3 | 2017 | 825 | 0.300 |
Why?
| Pregnancy | 17 | 2020 | 6357 | 0.290 |
Why?
| Feces | 3 | 2019 | 435 | 0.290 |
Why?
| Mice, Inbred C57BL | 12 | 2024 | 5272 | 0.290 |
Why?
| Acyl Coenzyme A | 5 | 2006 | 30 | 0.280 |
Why?
| Prevalence | 13 | 2017 | 2547 | 0.270 |
Why?
| Malnutrition | 1 | 2008 | 79 | 0.270 |
Why?
| Dietary Services | 2 | 2005 | 2 | 0.270 |
Why?
| Corrinoids | 2 | 2019 | 7 | 0.260 |
Why?
| Nutrition Assessment | 1 | 2006 | 85 | 0.260 |
Why?
| Sulfhydryl Compounds | 4 | 2018 | 185 | 0.260 |
Why?
| Amino Acids | 6 | 2020 | 474 | 0.250 |
Why?
| Antioxidants | 1 | 2009 | 538 | 0.250 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2021 | 281 | 0.250 |
Why?
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 7 | 2017 | 17 | 0.250 |
Why?
| Mice, Knockout | 10 | 2020 | 2755 | 0.240 |
Why?
| Human papillomavirus 16 | 2 | 2018 | 33 | 0.240 |
Why?
| Transcobalamins | 3 | 2017 | 4 | 0.240 |
Why?
| Disease Progression | 3 | 2011 | 2602 | 0.240 |
Why?
| Geriatrics | 2 | 2003 | 80 | 0.230 |
Why?
| Administration, Oral | 8 | 2019 | 754 | 0.230 |
Why?
| Vitamin B 6 | 2 | 2003 | 9 | 0.220 |
Why?
| Brain Diseases | 2 | 2020 | 135 | 0.220 |
Why?
| Maternal Nutritional Physiological Phenomena | 3 | 2015 | 169 | 0.220 |
Why?
| Rumen | 3 | 2014 | 4 | 0.220 |
Why?
| Food, Fortified | 4 | 2010 | 37 | 0.220 |
Why?
| Gestational Age | 3 | 2020 | 867 | 0.220 |
Why?
| Prostatic Neoplasms | 1 | 2011 | 1011 | 0.220 |
Why?
| Rats | 18 | 2016 | 5165 | 0.210 |
Why?
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 2 | 2012 | 2 | 0.200 |
Why?
| Mutation | 10 | 2017 | 3689 | 0.200 |
Why?
| Apolipoproteins E | 5 | 2013 | 78 | 0.200 |
Why?
| Neonatal Screening | 2 | 2007 | 163 | 0.200 |
Why?
| Uterine Artery | 2 | 2020 | 76 | 0.200 |
Why?
| Hearing Loss | 1 | 2006 | 210 | 0.200 |
Why?
| Fetal Blood | 5 | 2013 | 316 | 0.200 |
Why?
| Cohort Studies | 11 | 2020 | 5388 | 0.190 |
Why?
| Ferredoxin-NADP Reductase | 3 | 2012 | 3 | 0.190 |
Why?
| Heterozygote | 4 | 2015 | 267 | 0.190 |
Why?
| Protein Biosynthesis | 1 | 2004 | 397 | 0.190 |
Why?
| Metabolic Networks and Pathways | 2 | 2015 | 175 | 0.180 |
Why?
| Body Mass Index | 1 | 2009 | 2261 | 0.180 |
Why?
| Disabled Persons | 2 | 2000 | 140 | 0.180 |
Why?
| Nutrition Surveys | 3 | 2011 | 261 | 0.180 |
Why?
| Mice, Transgenic | 8 | 2014 | 2071 | 0.180 |
Why?
| Aging | 7 | 2010 | 1750 | 0.180 |
Why?
| Lactation | 4 | 2015 | 170 | 0.180 |
Why?
| Global Health | 1 | 2004 | 327 | 0.180 |
Why?
| Liver Diseases, Alcoholic | 3 | 2011 | 89 | 0.180 |
Why?
| Sulfites | 1 | 2020 | 7 | 0.180 |
Why?
| Formate-Tetrahydrofolate Ligase | 2 | 2012 | 2 | 0.180 |
Why?
| Cattle | 3 | 2014 | 960 | 0.180 |
Why?
| Polyamines | 1 | 2021 | 39 | 0.180 |
Why?
| Fetal Growth Retardation | 2 | 2020 | 543 | 0.180 |
Why?
| Anemia, Pernicious | 3 | 2013 | 9 | 0.180 |
Why?
| Brazil | 4 | 2009 | 154 | 0.170 |
Why?
| Animals, Newborn | 3 | 2007 | 803 | 0.170 |
Why?
| Carrier Proteins | 3 | 2014 | 732 | 0.170 |
Why?
| Erythrocytes | 8 | 2011 | 672 | 0.170 |
Why?
| Virus Integration | 2 | 2018 | 69 | 0.170 |
Why?
| Reference Values | 12 | 2010 | 776 | 0.170 |
Why?
| Aminobutyrates | 2 | 2018 | 33 | 0.170 |
Why?
| Genetic Diseases, Inborn | 2 | 2004 | 38 | 0.160 |
Why?
| Polymorphism, Genetic | 4 | 2015 | 639 | 0.160 |
Why?
| Caenorhabditis elegans | 2 | 2017 | 291 | 0.160 |
Why?
| Umbilical Arteries | 1 | 2020 | 51 | 0.160 |
Why?
| Depressive Disorder | 2 | 2000 | 360 | 0.160 |
Why?
| Bacteroides | 1 | 2019 | 19 | 0.160 |
Why?
| Gene Rearrangement | 1 | 2020 | 146 | 0.160 |
Why?
| Infant, Newborn | 14 | 2020 | 5687 | 0.160 |
Why?
| Carnitine | 2 | 1990 | 76 | 0.160 |
Why?
| Isomerases | 3 | 1988 | 8 | 0.150 |
Why?
| Vitamin B 6 Deficiency | 3 | 2011 | 5 | 0.150 |
Why?
| Hemophilia B | 2 | 2003 | 42 | 0.150 |
Why?
| Risk Factors | 15 | 2017 | 9704 | 0.150 |
Why?
| Adolescent | 28 | 2020 | 20179 | 0.150 |
Why?
| Sarcosine | 6 | 2012 | 10 | 0.150 |
Why?
| Liver Diseases | 2 | 2020 | 284 | 0.150 |
Why?
| Chromatography, Liquid | 4 | 2011 | 374 | 0.150 |
Why?
| Homozygote | 2 | 2015 | 192 | 0.150 |
Why?
| Genotype | 8 | 2015 | 1828 | 0.150 |
Why?
| Infant | 14 | 2015 | 8914 | 0.150 |
Why?
| Young Adult | 17 | 2020 | 12312 | 0.150 |
Why?
| Sulfinic Acids | 1 | 2018 | 8 | 0.150 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2011 | 1185 | 0.150 |
Why?
| Mass Spectrometry | 4 | 2017 | 659 | 0.150 |
Why?
| Georgia | 5 | 2013 | 78 | 0.140 |
Why?
| Geriatric Assessment | 4 | 2013 | 205 | 0.140 |
Why?
| Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.140 |
Why?
| Pyruvaldehyde | 1 | 2018 | 43 | 0.140 |
Why?
| Racemases and Epimerases | 2 | 2006 | 11 | 0.140 |
Why?
| Genetic Variation | 2 | 2015 | 933 | 0.140 |
Why?
| Lymphoma, AIDS-Related | 2 | 1996 | 14 | 0.140 |
Why?
| Thymidine Monophosphate | 3 | 2013 | 4 | 0.140 |
Why?
| Folate Receptor 2 | 1 | 2017 | 9 | 0.140 |
Why?
| Phosphatidylcholines | 5 | 2013 | 146 | 0.140 |
Why?
| Child, Preschool | 17 | 2020 | 10384 | 0.140 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2017 | 130 | 0.140 |
Why?
| ROC Curve | 2 | 2011 | 500 | 0.130 |
Why?
| Methyltransferases | 5 | 2008 | 69 | 0.130 |
Why?
| DNA, Mitochondrial | 3 | 2021 | 188 | 0.130 |
Why?
| Lung | 5 | 2012 | 3743 | 0.130 |
Why?
| Thromboembolism | 2 | 2015 | 102 | 0.130 |
Why?
| Carcinogenesis | 1 | 2018 | 209 | 0.130 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2020 | 508 | 0.130 |
Why?
| Hematinics | 2 | 2006 | 19 | 0.130 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2015 | 2062 | 0.130 |
Why?
| Propionates | 3 | 2017 | 33 | 0.130 |
Why?
| Crosses, Genetic | 2 | 2013 | 142 | 0.130 |
Why?
| Hemophilia A | 2 | 1996 | 75 | 0.130 |
Why?
| Diabetic Nephropathies | 1 | 1999 | 278 | 0.130 |
Why?
| Alleles | 5 | 2009 | 844 | 0.130 |
Why?
| Hydroxocobalamin | 3 | 1990 | 26 | 0.130 |
Why?
| Genome | 1 | 2018 | 277 | 0.120 |
Why?
| Stomach | 1 | 1996 | 109 | 0.120 |
Why?
| Alcoholism | 2 | 2020 | 766 | 0.120 |
Why?
| Neoplasms, Experimental | 2 | 2017 | 169 | 0.120 |
Why?
| Kidney Failure, Chronic | 2 | 2020 | 535 | 0.120 |
Why?
| Linear Models | 5 | 2010 | 813 | 0.120 |
Why?
| Pilot Projects | 3 | 2020 | 1564 | 0.120 |
Why?
| Phospholipids | 1 | 2017 | 207 | 0.120 |
Why?
| Weight Gain | 2 | 2016 | 503 | 0.120 |
Why?
| Glycine N-Methyltransferase | 3 | 2011 | 4 | 0.120 |
Why?
| Double-Blind Method | 7 | 2015 | 1848 | 0.120 |
Why?
| Age Factors | 6 | 2010 | 3103 | 0.120 |
Why?
| RNA, Messenger | 6 | 2017 | 2675 | 0.120 |
Why?
| Keratinocytes | 2 | 2018 | 243 | 0.120 |
Why?
| Thymidylate Synthase | 2 | 2011 | 12 | 0.120 |
Why?
| Choline Deficiency | 3 | 2012 | 11 | 0.120 |
Why?
| Milk, Human | 2 | 2015 | 148 | 0.120 |
Why?
| Biochemistry | 1 | 2015 | 38 | 0.120 |
Why?
| Host Cell Factor C1 | 1 | 2014 | 14 | 0.120 |
Why?
| DNA Methylation | 4 | 2018 | 604 | 0.120 |
Why?
| Placenta | 3 | 2017 | 716 | 0.120 |
Why?
| Dietary Fats | 1 | 2016 | 301 | 0.120 |
Why?
| Micronutrients | 1 | 2015 | 88 | 0.110 |
Why?
| Child | 16 | 2020 | 20655 | 0.110 |
Why?
| Energy Intake | 2 | 2015 | 454 | 0.110 |
Why?
| Hemoglobins, Abnormal | 1 | 1994 | 9 | 0.110 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2020 | 817 | 0.110 |
Why?
| Cross-Sectional Studies | 7 | 2010 | 5039 | 0.110 |
Why?
| Cyanosis | 1 | 1994 | 16 | 0.110 |
Why?
| Blotting, Western | 5 | 2014 | 1164 | 0.110 |
Why?
| Colitis | 2 | 2019 | 240 | 0.110 |
Why?
| Paresthesia | 2 | 2013 | 10 | 0.110 |
Why?
| Milk | 1 | 2014 | 119 | 0.110 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2020 | 591 | 0.110 |
Why?
| Time Factors | 7 | 2006 | 6482 | 0.110 |
Why?
| Drosophila melanogaster | 1 | 2015 | 217 | 0.110 |
Why?
| Benzimidazoles | 1 | 2014 | 157 | 0.110 |
Why?
| Lipid Metabolism | 1 | 2016 | 491 | 0.100 |
Why?
| Infant Nutrition Disorders | 1 | 2013 | 11 | 0.100 |
Why?
| Child Nutrition Disorders | 1 | 2013 | 19 | 0.100 |
Why?
| Papillomavirus Infections | 2 | 2018 | 290 | 0.100 |
Why?
| Malonates | 3 | 1990 | 7 | 0.100 |
Why?
| Analysis of Variance | 5 | 2011 | 1269 | 0.100 |
Why?
| Women's Health | 3 | 2015 | 362 | 0.100 |
Why?
| Chloroflexi | 1 | 2012 | 12 | 0.100 |
Why?
| Interleukin-1beta | 2 | 2011 | 373 | 0.100 |
Why?
| Maternal-Fetal Exchange | 1 | 2013 | 161 | 0.100 |
Why?
| Hemoglobins | 3 | 2011 | 336 | 0.100 |
Why?
| Apolipoproteins A | 1 | 2012 | 19 | 0.100 |
Why?
| Aminohydrolases | 1 | 2012 | 2 | 0.100 |
Why?
| Apolipoprotein A-I | 1 | 2012 | 28 | 0.100 |
Why?
| Injections | 1 | 2013 | 172 | 0.100 |
Why?
| Aryldialkylphosphatase | 1 | 2012 | 18 | 0.100 |
Why?
| Cell Transformation, Viral | 1 | 2012 | 27 | 0.100 |
Why?
| Kaplan-Meier Estimate | 2 | 2011 | 853 | 0.100 |
Why?
| Gene Expression Regulation | 3 | 2017 | 2505 | 0.100 |
Why?
| Fibroblasts | 6 | 2021 | 935 | 0.100 |
Why?
| Prospective Studies | 12 | 2013 | 7036 | 0.100 |
Why?
| Multienzyme Complexes | 1 | 2012 | 68 | 0.100 |
Why?
| Logistic Models | 4 | 2013 | 1974 | 0.100 |
Why?
| Pyridoxine | 3 | 1996 | 32 | 0.090 |
Why?
| Bone Density | 1 | 2015 | 474 | 0.090 |
Why?
| Diagnostic Errors | 1 | 2013 | 160 | 0.090 |
Why?
| Neurogenesis | 1 | 2013 | 126 | 0.090 |
Why?
| Zebrafish Proteins | 1 | 2014 | 269 | 0.090 |
Why?
| Oxidative Stress | 4 | 2019 | 1176 | 0.090 |
Why?
| Cognition | 2 | 2013 | 1107 | 0.090 |
Why?
| Memory | 1 | 2013 | 232 | 0.090 |
Why?
| Pregnancy Complications | 2 | 2009 | 487 | 0.090 |
Why?
| Inflammation | 3 | 2019 | 2654 | 0.090 |
Why?
| Cell Nucleus | 2 | 2011 | 578 | 0.090 |
Why?
| Vitamins | 3 | 2007 | 174 | 0.090 |
Why?
| Mutation, Missense | 4 | 2009 | 315 | 0.090 |
Why?
| Polymorphism, Restriction Fragment Length | 2 | 2008 | 69 | 0.090 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2011 | 167 | 0.090 |
Why?
| Hydrops Fetalis | 1 | 2010 | 13 | 0.090 |
Why?
| Superoxide Dismutase | 1 | 1993 | 326 | 0.090 |
Why?
| RNA-Binding Proteins | 3 | 2017 | 388 | 0.090 |
Why?
| Nutritional Requirements | 2 | 2010 | 77 | 0.090 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 384 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 940 | 0.090 |
Why?
| Polymerase Chain Reaction | 3 | 2009 | 1020 | 0.090 |
Why?
| Sensitivity and Specificity | 5 | 2009 | 1815 | 0.090 |
Why?
| Cell Line | 4 | 2017 | 2731 | 0.090 |
Why?
| Coenzyme A | 1 | 1990 | 8 | 0.090 |
Why?
| Lactams | 1 | 1990 | 21 | 0.090 |
Why?
| Proportional Hazards Models | 2 | 2011 | 1196 | 0.080 |
Why?
| Chemokines | 1 | 2011 | 221 | 0.080 |
Why?
| Blood Coagulation | 1 | 2011 | 227 | 0.080 |
Why?
| Creatinine | 4 | 2011 | 475 | 0.080 |
Why?
| Hematocrit | 4 | 2002 | 93 | 0.080 |
Why?
| Endoplasmic Reticulum | 1 | 2012 | 260 | 0.080 |
Why?
| Treatment Outcome | 8 | 2013 | 10152 | 0.080 |
Why?
| Mice, Nude | 3 | 2018 | 682 | 0.080 |
Why?
| Siblings | 1 | 2010 | 215 | 0.080 |
Why?
| Kidney | 2 | 2007 | 1302 | 0.080 |
Why?
| Leukocytes | 2 | 2015 | 303 | 0.080 |
Why?
| Endothelium, Vascular | 2 | 2006 | 847 | 0.080 |
Why?
| Mitochondrial Proteins | 1 | 2011 | 244 | 0.080 |
Why?
| DNA-Binding Proteins | 4 | 2017 | 1421 | 0.080 |
Why?
| Educational Status | 2 | 2003 | 470 | 0.080 |
Why?
| Neuropsychological Tests | 3 | 2013 | 1002 | 0.080 |
Why?
| Gastrointestinal Contents | 1 | 2009 | 7 | 0.080 |
Why?
| Antibodies, Bacterial | 1 | 2010 | 135 | 0.080 |
Why?
| Formates | 1 | 2008 | 13 | 0.080 |
Why?
| Neoplasm Metastasis | 1 | 2011 | 608 | 0.080 |
Why?
| Glutamate Carboxypeptidase II | 1 | 2008 | 5 | 0.080 |
Why?
| Deuterium | 3 | 2015 | 86 | 0.080 |
Why?
| Reduced Folate Carrier Protein | 1 | 2008 | 10 | 0.080 |
Why?
| Homeostasis | 2 | 2020 | 603 | 0.080 |
Why?
| Atherosclerosis | 1 | 2013 | 403 | 0.080 |
Why?
| Fatty Liver | 2 | 2010 | 231 | 0.080 |
Why?
| Amino Acid Isomerases | 1 | 1988 | 1 | 0.080 |
Why?
| Intramolecular Transferases | 1 | 1988 | 3 | 0.080 |
Why?
| Lipids | 1 | 2012 | 620 | 0.080 |
Why?
| Biological Availability | 2 | 2010 | 122 | 0.070 |
Why?
| Cardiovascular Diseases | 1 | 2020 | 1999 | 0.070 |
Why?
| Hippocampus | 1 | 2013 | 801 | 0.070 |
Why?
| Recurrence | 1 | 2011 | 996 | 0.070 |
Why?
| Oxygen | 1 | 1993 | 899 | 0.070 |
Why?
| Rats, Sprague-Dawley | 3 | 2009 | 2239 | 0.070 |
Why?
| Cytoplasm | 1 | 2008 | 257 | 0.070 |
Why?
| Promoter Regions, Genetic | 1 | 2012 | 1198 | 0.070 |
Why?
| Folate Receptors, GPI-Anchored | 2 | 2005 | 5 | 0.070 |
Why?
| Leucine | 1 | 1988 | 108 | 0.070 |
Why?
| Nutritional Physiological Phenomena | 1 | 2007 | 53 | 0.070 |
Why?
| Parity | 1 | 2008 | 120 | 0.070 |
Why?
| Socioeconomic Factors | 3 | 2008 | 1212 | 0.070 |
Why?
| Muscle, Skeletal | 2 | 2007 | 1627 | 0.070 |
Why?
| Obesity | 1 | 2020 | 2858 | 0.070 |
Why?
| Regression Analysis | 2 | 2000 | 978 | 0.070 |
Why?
| Cobalt | 3 | 2014 | 51 | 0.070 |
Why?
| Pregnancy Trimester, Third | 2 | 2020 | 107 | 0.070 |
Why?
| Succinates | 4 | 1991 | 22 | 0.070 |
Why?
| Iron | 2 | 2008 | 282 | 0.070 |
Why?
| Afibrinogenemia | 1 | 2006 | 1 | 0.070 |
Why?
| Fibrinogens, Abnormal | 1 | 2006 | 4 | 0.070 |
Why?
| Thrombin Time | 1 | 2006 | 11 | 0.070 |
Why?
| Base Sequence | 4 | 2015 | 2135 | 0.070 |
Why?
| Mitochondria | 3 | 2021 | 848 | 0.070 |
Why?
| Succinic Acid | 4 | 1991 | 38 | 0.070 |
Why?
| Diagnosis, Differential | 4 | 2006 | 1416 | 0.070 |
Why?
| Smoking | 2 | 2012 | 1460 | 0.070 |
Why?
| Cobamides | 1 | 2006 | 20 | 0.060 |
Why?
| Diabetes Mellitus, Type 2 | 2 | 2001 | 2430 | 0.060 |
Why?
| Cardiotonic Agents | 1 | 2006 | 124 | 0.060 |
Why?
| Reproduction | 1 | 2007 | 199 | 0.060 |
Why?
| Social Class | 2 | 2005 | 258 | 0.060 |
Why?
| Dextran Sulfate | 2 | 2019 | 76 | 0.060 |
Why?
| Homocystine | 1 | 2005 | 1 | 0.060 |
Why?
| Acquired Immunodeficiency Syndrome | 3 | 1999 | 222 | 0.060 |
Why?
| Severity of Illness Index | 5 | 2011 | 2722 | 0.060 |
Why?
| Mass Screening | 3 | 2002 | 1147 | 0.060 |
Why?
| Oncogene Proteins, Viral | 2 | 2018 | 22 | 0.060 |
Why?
| Acidosis | 1 | 2006 | 88 | 0.060 |
Why?
| Disulfides | 2 | 2008 | 96 | 0.060 |
Why?
| Membrane Proteins | 1 | 2011 | 1105 | 0.060 |
Why?
| Fetus | 2 | 2012 | 760 | 0.060 |
Why?
| Transfection | 2 | 2006 | 893 | 0.060 |
Why?
| Recommended Dietary Allowances | 2 | 2015 | 19 | 0.060 |
Why?
| Brain Edema | 2 | 2003 | 60 | 0.060 |
Why?
| Kidney Diseases | 2 | 2007 | 367 | 0.060 |
Why?
| Molecular Sequence Data | 4 | 2012 | 2819 | 0.060 |
Why?
| Food Services | 1 | 2005 | 19 | 0.060 |
Why?
| Practice Guidelines as Topic | 1 | 2013 | 1478 | 0.060 |
Why?
| Hyperoxia | 1 | 2005 | 87 | 0.060 |
Why?
| Zinc | 1 | 2008 | 292 | 0.060 |
Why?
| Epidemiologic Methods | 1 | 2005 | 73 | 0.060 |
Why?
| Uterine Cervical Neoplasms | 2 | 2018 | 232 | 0.060 |
Why?
| Biomarkers, Tumor | 1 | 2011 | 1181 | 0.060 |
Why?
| Hemorrhage | 2 | 2006 | 645 | 0.060 |
Why?
| Apoptosis | 2 | 2012 | 2435 | 0.060 |
Why?
| Intestinal Mucosa | 1 | 2009 | 575 | 0.060 |
Why?
| Carotid Stenosis | 1 | 2005 | 85 | 0.060 |
Why?
| Postoperative Complications | 1 | 1996 | 2485 | 0.060 |
Why?
| Gene Expression | 3 | 2018 | 1456 | 0.060 |
Why?
| Diet, Vegetarian | 1 | 2004 | 8 | 0.060 |
Why?
| Menopause | 1 | 2007 | 291 | 0.060 |
Why?
| Brain | 5 | 2012 | 2620 | 0.060 |
Why?
| Indicator Dilution Techniques | 1 | 2003 | 11 | 0.060 |
Why?
| Neoplasms | 2 | 2018 | 2464 | 0.060 |
Why?
| Liver Cirrhosis | 2 | 2010 | 275 | 0.060 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2006 | 191 | 0.050 |
Why?
| Pregnancy Complications, Infectious | 1 | 2008 | 364 | 0.050 |
Why?
| 5' Untranslated Regions | 1 | 2004 | 55 | 0.050 |
Why?
| Testosterone | 1 | 2007 | 373 | 0.050 |
Why?
| Mental Disorders | 3 | 1998 | 1027 | 0.050 |
Why?
| Fasting | 5 | 2004 | 264 | 0.050 |
Why?
| Sex Factors | 3 | 2010 | 1945 | 0.050 |
Why?
| Arginine | 1 | 2005 | 258 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 2 | 2001 | 160 | 0.050 |
Why?
| Epithelial Cells | 2 | 2008 | 1032 | 0.050 |
Why?
| Factor IX | 1 | 2003 | 36 | 0.050 |
Why?
| Protein Binding | 2 | 2012 | 2103 | 0.050 |
Why?
| Nutritional Support | 1 | 2003 | 31 | 0.050 |
Why?
| Infant Food | 1 | 2003 | 65 | 0.050 |
Why?
| Smoke | 1 | 2004 | 131 | 0.050 |
Why?
| Lyases | 1 | 2002 | 9 | 0.050 |
Why?
| Kinetics | 6 | 2007 | 1615 | 0.050 |
Why?
| Mutagenesis, Insertional | 2 | 2012 | 65 | 0.050 |
Why?
| Cell Line, Tumor | 3 | 2005 | 3184 | 0.050 |
Why?
| Connective Tissue | 1 | 2002 | 38 | 0.050 |
Why?
| Brachial Artery | 2 | 2019 | 190 | 0.050 |
Why?
| Glutamates | 1 | 2002 | 56 | 0.050 |
Why?
| HeLa Cells | 1 | 2004 | 603 | 0.050 |
Why?
| Guanine | 1 | 2002 | 76 | 0.050 |
Why?
| Mice, Mutant Strains | 2 | 2012 | 292 | 0.050 |
Why?
| Surveys and Questionnaires | 4 | 2015 | 5362 | 0.050 |
Why?
| Vascular Diseases | 3 | 2004 | 232 | 0.050 |
Why?
| Pyridoxal Phosphate | 2 | 2011 | 21 | 0.050 |
Why?
| Phenotype | 4 | 2014 | 3044 | 0.050 |
Why?
| Methotrexate | 2 | 2015 | 248 | 0.050 |
Why?
| Down-Regulation | 1 | 2004 | 631 | 0.050 |
Why?
| Birth Weight | 1 | 2004 | 498 | 0.050 |
Why?
| Antigens, CD | 2 | 2001 | 482 | 0.050 |
Why?
| Pregnancy Outcome | 2 | 2020 | 389 | 0.050 |
Why?
| Molecular Weight | 5 | 1988 | 331 | 0.050 |
Why?
| Models, Biological | 4 | 2012 | 1691 | 0.040 |
Why?
| Malonyl Coenzyme A | 3 | 1990 | 5 | 0.040 |
Why?
| Quinolinic Acid | 1 | 2000 | 8 | 0.040 |
Why?
| Respiration | 1 | 2021 | 190 | 0.040 |
Why?
| Case-Control Studies | 5 | 2010 | 3328 | 0.040 |
Why?
| New York | 2 | 2015 | 124 | 0.040 |
Why?
| Papio | 1 | 2000 | 91 | 0.040 |
Why?
| Citrates | 3 | 1998 | 42 | 0.040 |
Why?
| Anemia, Macrocytic | 1 | 2000 | 4 | 0.040 |
Why?
| Neurocognitive Disorders | 2 | 1992 | 23 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 2 | 1994 | 475 | 0.040 |
Why?
| Coronary Artery Disease | 1 | 2006 | 678 | 0.040 |
Why?
| Diabetic Neuropathies | 1 | 2001 | 90 | 0.040 |
Why?
| Reverse Transcriptase Inhibitors | 1 | 2000 | 81 | 0.040 |
Why?
| Sampling Studies | 1 | 2000 | 96 | 0.040 |
Why?
| Genetic Testing | 1 | 2003 | 428 | 0.040 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2001 | 266 | 0.040 |
Why?
| Oncogenes | 1 | 2020 | 109 | 0.040 |
Why?
| Odds Ratio | 3 | 2002 | 1023 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2003 | 1281 | 0.040 |
Why?
| Nervous System Diseases | 2 | 1996 | 252 | 0.040 |
Why?
| Parenteral Nutrition | 1 | 2000 | 104 | 0.040 |
Why?
| Blotting, Northern | 3 | 2007 | 198 | 0.040 |
Why?
| Activities of Daily Living | 1 | 2003 | 384 | 0.040 |
Why?
| Embryo, Mammalian | 1 | 2020 | 226 | 0.040 |
Why?
| Cecum | 1 | 2019 | 32 | 0.040 |
Why?
| Infant, Small for Gestational Age | 1 | 2020 | 84 | 0.040 |
Why?
| Ultrasonography, Doppler | 1 | 2020 | 121 | 0.040 |
Why?
| Peripheral Nervous System Diseases | 1 | 2000 | 123 | 0.040 |
Why?
| Stroke | 2 | 2005 | 1063 | 0.040 |
Why?
| Metabolomics | 2 | 2017 | 599 | 0.040 |
Why?
| Species Specificity | 2 | 2007 | 568 | 0.040 |
Why?
| Kidney Function Tests | 1 | 1999 | 145 | 0.040 |
Why?
| Reticulocyte Count | 2 | 2000 | 6 | 0.040 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 323 | 0.040 |
Why?
| Pancytopenia | 1 | 1999 | 8 | 0.040 |
Why?
| Fatty Acids, Volatile | 1 | 2019 | 57 | 0.040 |
Why?
| Terminology as Topic | 1 | 2000 | 202 | 0.040 |
Why?
| RNA | 2 | 2004 | 880 | 0.040 |
Why?
| Income | 1 | 1999 | 189 | 0.040 |
Why?
| Albuminuria | 1 | 1999 | 181 | 0.040 |
Why?
| Oligodendroglia | 1 | 2000 | 166 | 0.040 |
Why?
| Papillomavirus E7 Proteins | 1 | 2018 | 10 | 0.040 |
Why?
| Nutrition Policy | 2 | 2010 | 56 | 0.040 |
Why?
| Cross-Over Studies | 2 | 2014 | 513 | 0.040 |
Why?
| Estrogens | 1 | 2020 | 342 | 0.040 |
Why?
| Ultrasonography, Prenatal | 1 | 2020 | 270 | 0.040 |
Why?
| gamma-Glutamyltransferase | 1 | 2018 | 40 | 0.040 |
Why?
| Tissue Distribution | 2 | 2011 | 291 | 0.040 |
Why?
| Alcohol Drinking | 2 | 2001 | 752 | 0.040 |
Why?
| Exons | 2 | 2011 | 338 | 0.040 |
Why?
| Central Nervous System Diseases | 1 | 1998 | 67 | 0.030 |
Why?
| Anti-HIV Agents | 2 | 2001 | 747 | 0.030 |
Why?
| Aspartate Aminotransferases | 2 | 2011 | 85 | 0.030 |
Why?
| Lysosomes | 1 | 2017 | 135 | 0.030 |
Why?
| Cytosol | 1 | 2017 | 214 | 0.030 |
Why?
| Acetylcysteine | 2 | 2010 | 140 | 0.030 |
Why?
| History, 20th Century | 2 | 2015 | 291 | 0.030 |
Why?
| Angina Pectoris | 1 | 1997 | 67 | 0.030 |
Why?
| Alanine Transaminase | 2 | 2011 | 150 | 0.030 |
Why?
| United States | 3 | 2020 | 13830 | 0.030 |
Why?
| 3T3-L1 Cells | 1 | 2016 | 34 | 0.030 |
Why?
| Chronic Disease | 2 | 2011 | 1705 | 0.030 |
Why?
| Biological Transport | 1 | 2017 | 394 | 0.030 |
Why?
| HIV Infections | 2 | 2001 | 2701 | 0.030 |
Why?
| L-Lactate Dehydrogenase | 2 | 2000 | 116 | 0.030 |
Why?
| Enzyme Activation | 3 | 2005 | 799 | 0.030 |
Why?
| Fatal Outcome | 2 | 2010 | 300 | 0.030 |
Why?
| Magnetic Resonance Imaging | 5 | 2006 | 3376 | 0.030 |
Why?
| Denmark | 1 | 2015 | 44 | 0.030 |
Why?
| Cells, Cultured | 3 | 2012 | 4001 | 0.030 |
Why?
| Glomerular Filtration Rate | 2 | 2011 | 681 | 0.030 |
Why?
| Lymphoma, Non-Hodgkin | 1 | 1996 | 76 | 0.030 |
Why?
| Sulfaquinoxaline | 1 | 2015 | 1 | 0.030 |
Why?
| Food, Formulated | 1 | 2015 | 14 | 0.030 |
Why?
| Carbon Cycle | 1 | 2015 | 16 | 0.030 |
Why?
| Body Weight | 2 | 2011 | 928 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2018 | 356 | 0.030 |
Why?
| Hematologic Diseases | 1 | 1996 | 61 | 0.030 |
Why?
| Coronary Artery Bypass | 1 | 1997 | 221 | 0.030 |
Why?
| Enzyme Induction | 1 | 2015 | 89 | 0.030 |
Why?
| Comorbidity | 1 | 2000 | 1543 | 0.030 |
Why?
| Pregnancy Trimester, Second | 1 | 1995 | 78 | 0.030 |
Why?
| Histones | 1 | 2020 | 586 | 0.030 |
Why?
| Cell Proliferation | 2 | 2013 | 2344 | 0.030 |
Why?
| Hyaline Membrane Disease | 1 | 1994 | 20 | 0.030 |
Why?
| Omasum | 1 | 2014 | 1 | 0.030 |
Why?
| Parenteral Nutrition, Total | 1 | 1994 | 26 | 0.030 |
Why?
| Metabolome | 1 | 2018 | 319 | 0.030 |
Why?
| Mammary Glands, Human | 1 | 2015 | 64 | 0.030 |
Why?
| Fermentation | 1 | 2014 | 26 | 0.030 |
Why?
| Cricetinae | 2 | 2007 | 275 | 0.030 |
Why?
| Repressor Proteins | 1 | 2018 | 399 | 0.030 |
Why?
| Cysteine Dioxygenase | 1 | 2014 | 3 | 0.030 |
Why?
| Branchial Region | 1 | 2014 | 35 | 0.030 |
Why?
| Carboxy-Lyases | 1 | 2014 | 8 | 0.030 |
Why?
| Renal Insufficiency | 2 | 1993 | 148 | 0.030 |
Why?
| Larva | 1 | 2015 | 211 | 0.030 |
Why?
| Intrinsic Factor | 2 | 2010 | 2 | 0.030 |
Why?
| Family Health | 2 | 2006 | 196 | 0.030 |
Why?
| Healthy Volunteers | 1 | 2015 | 202 | 0.030 |
Why?
| Isoelectric Focusing | 1 | 1994 | 34 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2017 | 449 | 0.030 |
Why?
| Electrophoresis | 1 | 1994 | 30 | 0.030 |
Why?
| History, 21st Century | 1 | 2015 | 181 | 0.030 |
Why?
| Craniofacial Abnormalities | 1 | 2014 | 63 | 0.030 |
Why?
| Oxidoreductases | 1 | 2014 | 89 | 0.030 |
Why?
| Myocardial Infarction | 2 | 2004 | 1015 | 0.030 |
Why?
| Radioisotope Dilution Technique | 3 | 1988 | 13 | 0.030 |
Why?
| Anti-Bacterial Agents | 2 | 2015 | 1663 | 0.030 |
Why?
| Body Patterning | 1 | 2014 | 128 | 0.030 |
Why?
| Follow-Up Studies | 3 | 2015 | 4892 | 0.030 |
Why?
| Chromatography, Affinity | 3 | 1988 | 83 | 0.030 |
Why?
| Animal Feed | 2 | 2009 | 50 | 0.030 |
Why?
| Blood Glucose | 2 | 2016 | 2093 | 0.030 |
Why?
| RNA, Viral | 2 | 2012 | 616 | 0.030 |
Why?
| Neural Crest | 1 | 2014 | 114 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2014 | 312 | 0.030 |
Why?
| Mammals | 1 | 2015 | 268 | 0.030 |
Why?
| Coronary Disease | 1 | 1996 | 382 | 0.030 |
Why?
| Dentate Gyrus | 1 | 2013 | 30 | 0.030 |
Why?
| Hydrolysis | 1 | 2013 | 184 | 0.030 |
Why?
| Persistent Fetal Circulation Syndrome | 1 | 1994 | 136 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 324 | 0.030 |
Why?
| Litter Size | 1 | 2013 | 17 | 0.030 |
Why?
| Avitaminosis | 2 | 2007 | 7 | 0.030 |
Why?
| Receptors, CCR2 | 1 | 2013 | 37 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2014 | 380 | 0.030 |
Why?
| Rats, Inbred F344 | 2 | 1990 | 251 | 0.030 |
Why?
| Stroke Volume | 1 | 1996 | 586 | 0.030 |
Why?
| Tetrachloroethylene | 1 | 2012 | 4 | 0.030 |
Why?
| Pedigree | 1 | 1994 | 486 | 0.030 |
Why?
| Trichloroethylene | 1 | 2012 | 7 | 0.030 |
Why?
| Cell Differentiation | 2 | 2014 | 1900 | 0.030 |
Why?
| Ethylenes | 1 | 2012 | 12 | 0.030 |
Why?
| In Situ Hybridization | 1 | 2013 | 292 | 0.030 |
Why?
| Tunicamycin | 1 | 2012 | 11 | 0.030 |
Why?
| Eating | 1 | 2015 | 368 | 0.030 |
Why?
| Patient Selection | 1 | 1996 | 663 | 0.030 |
Why?
| Hep G2 Cells | 1 | 2012 | 61 | 0.020 |
Why?
| Mutant Proteins | 1 | 2012 | 98 | 0.020 |
Why?
| Lipotropic Agents | 1 | 2012 | 5 | 0.020 |
Why?
| Neurologic Examination | 1 | 1992 | 115 | 0.020 |
Why?
| Ventricular Function, Left | 1 | 1996 | 524 | 0.020 |
Why?
| Adipose Tissue | 1 | 2016 | 589 | 0.020 |
Why?
| Protein Denaturation | 1 | 2012 | 74 | 0.020 |
Why?
| Sarcoma, Kaposi | 1 | 1993 | 76 | 0.020 |
Why?
| Biodegradation, Environmental | 1 | 2012 | 82 | 0.020 |
Why?
| Carboxylic Ester Hydrolases | 1 | 2012 | 19 | 0.020 |
Why?
| Chondrocytes | 1 | 2014 | 203 | 0.020 |
Why?
| Embryo Loss | 1 | 2012 | 4 | 0.020 |
Why?
| HIV Seropositivity | 1 | 1993 | 119 | 0.020 |
Why?
| Genes, Lethal | 1 | 2012 | 29 | 0.020 |
Why?
| Postpartum Period | 1 | 2015 | 330 | 0.020 |
Why?
| Hypoxanthine | 1 | 2012 | 11 | 0.020 |
Why?
| Carcinoma, Basal Cell | 1 | 1993 | 73 | 0.020 |
Why?
| Lipoproteins | 1 | 2013 | 171 | 0.020 |
Why?
| Random Allocation | 1 | 2012 | 343 | 0.020 |
Why?
| Catalase | 1 | 2012 | 122 | 0.020 |
Why?
| Factor Analysis, Statistical | 1 | 2013 | 283 | 0.020 |
Why?
| S Phase | 1 | 2011 | 73 | 0.020 |
Why?
| Necrosis | 1 | 2012 | 229 | 0.020 |
Why?
| Diet, High-Fat | 1 | 2013 | 238 | 0.020 |
Why?
| Radioligand Assay | 1 | 2011 | 46 | 0.020 |
Why?
| Gastrointestinal Microbiome | 1 | 2019 | 633 | 0.020 |
Why?
| Ferritins | 1 | 2011 | 58 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2011 | 113 | 0.020 |
Why?
| Chemokine CCL4 | 1 | 2011 | 23 | 0.020 |
Why?
| Ethanol | 1 | 1996 | 584 | 0.020 |
Why?
| Proteolysis | 1 | 2012 | 162 | 0.020 |
Why?
| Microbiological Techniques | 1 | 2011 | 30 | 0.020 |
Why?
| Breast Feeding | 1 | 2015 | 422 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2001 | 42 | 0.020 |
Why?
| Capsid Proteins | 1 | 2012 | 91 | 0.020 |
Why?
| Genes, Reporter | 1 | 2012 | 265 | 0.020 |
Why?
| Neuroblastoma | 1 | 2012 | 154 | 0.020 |
Why?
| Sequence Deletion | 1 | 2011 | 178 | 0.020 |
Why?
| Chromatography, Ion Exchange | 2 | 1988 | 52 | 0.020 |
Why?
| Nitrous Oxide | 1 | 1991 | 22 | 0.020 |
Why?
| Epithelium | 1 | 2012 | 306 | 0.020 |
Why?
| Chromatography, Gel | 2 | 1988 | 127 | 0.020 |
Why?
| Protein Conformation | 1 | 1994 | 852 | 0.020 |
Why?
| Cholesterol | 1 | 2013 | 406 | 0.020 |
Why?
| Mice, 129 Strain | 1 | 2011 | 79 | 0.020 |
Why?
| Interleukin-1alpha | 1 | 2011 | 56 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1991 | 356 | 0.020 |
Why?
| Mitochondrial Diseases | 1 | 2011 | 88 | 0.020 |
Why?
| Lung Neoplasms | 1 | 2004 | 2328 | 0.020 |
Why?
| Renal Dialysis | 1 | 1995 | 417 | 0.020 |
Why?
| Transgenes | 1 | 2011 | 176 | 0.020 |
Why?
| Tumor Burden | 1 | 2012 | 283 | 0.020 |
Why?
| Gastrins | 1 | 1990 | 9 | 0.020 |
Why?
| Reference Standards | 1 | 2011 | 168 | 0.020 |
Why?
| Serum Albumin | 1 | 2011 | 145 | 0.020 |
Why?
| Acid Anhydride Hydrolases | 1 | 2010 | 6 | 0.020 |
Why?
| Peroxidase | 1 | 2011 | 169 | 0.020 |
Why?
| Macromolecular Substances | 2 | 1988 | 211 | 0.020 |
Why?
| Placebos | 2 | 2005 | 201 | 0.020 |
Why?
| Interleukin-17 | 1 | 2011 | 106 | 0.020 |
Why?
| Psychiatric Status Rating Scales | 1 | 2013 | 528 | 0.020 |
Why?
| Mitochondria, Liver | 1 | 1990 | 73 | 0.020 |
Why?
| Liver Cirrhosis, Alcoholic | 1 | 2010 | 17 | 0.020 |
Why?
| Staining and Labeling | 1 | 2010 | 137 | 0.020 |
Why?
| Hypertension | 1 | 1999 | 1235 | 0.020 |
Why?
| Hydroxybutyrates | 1 | 1990 | 11 | 0.020 |
Why?
| Aorta | 1 | 2013 | 404 | 0.020 |
Why?
| Bilirubin | 1 | 1990 | 92 | 0.020 |
Why?
| Zebrafish | 1 | 2014 | 464 | 0.020 |
Why?
| Stem Cells | 1 | 2014 | 578 | 0.020 |
Why?
| Fear | 1 | 2013 | 325 | 0.020 |
Why?
| Monocytes | 1 | 2013 | 542 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 1994 | 2040 | 0.020 |
Why?
| Hemostasis | 1 | 2010 | 71 | 0.020 |
Why?
| Cell Movement | 1 | 2014 | 936 | 0.020 |
Why?
| Purines | 1 | 2011 | 169 | 0.020 |
Why?
| Structure-Activity Relationship | 1 | 1991 | 530 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2013 | 495 | 0.020 |
Why?
| Dairying | 1 | 2009 | 7 | 0.020 |
Why?
| Helicobacter pylori | 1 | 2010 | 37 | 0.020 |
Why?
| HEK293 Cells | 1 | 2012 | 683 | 0.020 |
Why?
| Mexican Americans | 1 | 2010 | 113 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2012 | 345 | 0.020 |
Why?
| Nigeria | 1 | 2009 | 15 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 756 | 0.020 |
Why?
| Burkitt Lymphoma | 1 | 1989 | 56 | 0.020 |
Why?
| Interleukin-10 | 1 | 2011 | 299 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2011 | 397 | 0.020 |
Why?
| Osteosarcoma | 1 | 1989 | 72 | 0.020 |
Why?
| Body Composition | 1 | 2013 | 644 | 0.020 |
Why?
| Acetylcarnitine | 1 | 1988 | 4 | 0.020 |
Why?
| Peroxides | 1 | 2008 | 18 | 0.020 |
Why?
| Muscles | 1 | 1990 | 322 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2013 | 1098 | 0.020 |
Why?
| Bacteria | 1 | 2015 | 808 | 0.020 |
Why?
| Health Status Disparities | 1 | 2011 | 254 | 0.020 |
Why?
| Ambulatory Care | 1 | 1992 | 503 | 0.020 |
Why?
| Host-Pathogen Interactions | 1 | 2012 | 346 | 0.020 |
Why?
| Tandem Mass Spectrometry | 1 | 2011 | 449 | 0.020 |
Why?
| Duodenum | 1 | 2009 | 71 | 0.020 |
Why?
| Alzheimer Disease | 1 | 1994 | 516 | 0.020 |
Why?
| Microchemistry | 1 | 1988 | 17 | 0.020 |
Why?
| Predictive Value of Tests | 3 | 2000 | 1935 | 0.020 |
Why?
| Isoleucine | 1 | 1988 | 14 | 0.020 |
Why?
| Silicon | 1 | 1988 | 14 | 0.020 |
Why?
| Blood Coagulation Disorders | 1 | 2010 | 162 | 0.020 |
Why?
| Amino Acids, Branched-Chain | 1 | 1988 | 36 | 0.020 |
Why?
| Ethiopia | 1 | 2008 | 35 | 0.020 |
Why?
| Pyrimidines | 1 | 2011 | 445 | 0.020 |
Why?
| Catalytic Domain | 1 | 2009 | 217 | 0.020 |
Why?
| Tritium | 1 | 1988 | 75 | 0.020 |
Why?
| Multivariate Analysis | 2 | 2002 | 1484 | 0.020 |
Why?
| Haplotypes | 1 | 2010 | 471 | 0.020 |
Why?
| Thiolester Hydrolases | 1 | 1988 | 13 | 0.020 |
Why?
| Ileum | 1 | 2009 | 115 | 0.020 |
Why?
| Zea mays | 1 | 2008 | 41 | 0.020 |
Why?
| Valine | 1 | 1988 | 74 | 0.020 |
Why?
| Biopsy | 1 | 2011 | 1081 | 0.020 |
Why?
| Animals, Genetically Modified | 1 | 2008 | 231 | 0.020 |
Why?
| Embryonic Development | 1 | 2008 | 114 | 0.020 |
Why?
| Fibrosis | 1 | 2010 | 512 | 0.020 |
Why?
| Kidney Cortex | 1 | 2007 | 25 | 0.020 |
Why?
| Gene Deletion | 1 | 2009 | 370 | 0.020 |
Why?
| Feeding Behavior | 1 | 2013 | 618 | 0.020 |
Why?
| Guanidinoacetate N-Methyltransferase | 1 | 2007 | 5 | 0.020 |
Why?
| Interleukin-6 | 1 | 2011 | 716 | 0.020 |
Why?
| Ambulatory Care Facilities | 1 | 2009 | 226 | 0.020 |
Why?
| Guinea Pigs | 1 | 2007 | 155 | 0.020 |
Why?
| Infusions, Intravenous | 2 | 2003 | 385 | 0.020 |
Why?
| Injections, Intramuscular | 2 | 1998 | 116 | 0.020 |
Why?
| Creatine | 1 | 2007 | 55 | 0.020 |
Why?
| Prenatal Care | 1 | 2009 | 273 | 0.020 |
Why?
| Genetic Complementation Test | 1 | 2006 | 63 | 0.020 |
Why?
| von Willebrand Diseases | 1 | 2006 | 20 | 0.020 |
Why?
| Public Health | 1 | 2011 | 482 | 0.020 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 278 | 0.020 |
Why?
| von Willebrand Factor | 1 | 2006 | 63 | 0.020 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 377 | 0.020 |
Why?
| Alkyl and Aryl Transferases | 1 | 2006 | 53 | 0.020 |
Why?
| Respiratory Mucosa | 1 | 2008 | 304 | 0.020 |
Why?
| Gene Frequency | 1 | 2007 | 504 | 0.020 |
Why?
| Dicarboxylic Acids | 1 | 1985 | 6 | 0.020 |
Why?
| Rabbits | 1 | 2007 | 758 | 0.020 |
Why?
| Muscular Diseases | 1 | 2006 | 108 | 0.020 |
Why?
| Models, Genetic | 1 | 2008 | 591 | 0.020 |
Why?
| Edible Grain | 1 | 2005 | 48 | 0.020 |
Why?
| Croatia | 1 | 2005 | 5 | 0.020 |
Why?
| Transaminases | 1 | 2005 | 23 | 0.010 |
Why?
| Dipeptides | 1 | 2005 | 48 | 0.010 |
Why?
| HIV-1 | 2 | 2001 | 836 | 0.010 |
Why?
| Creatine Kinase | 1 | 2005 | 74 | 0.010 |
Why?
| Retrospective Studies | 2 | 2011 | 14454 | 0.010 |
Why?
| Neurons | 1 | 2013 | 1448 | 0.010 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 83 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2013 | 1923 | 0.010 |
Why?
| RNA Interference | 1 | 2006 | 441 | 0.010 |
Why?
| New York City | 1 | 2004 | 81 | 0.010 |
Why?
| Metals | 1 | 1985 | 127 | 0.010 |
Why?
| tert-Butylhydroperoxide | 1 | 2004 | 9 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 2007 | 1228 | 0.010 |
Why?
| Apolipoprotein E4 | 1 | 2004 | 34 | 0.010 |
Why?
| Models, Molecular | 1 | 2009 | 1480 | 0.010 |
Why?
| Depression | 1 | 2013 | 1296 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2005 | 930 | 0.010 |
Why?
| Psychological Tests | 1 | 2004 | 132 | 0.010 |
Why?
| Ascorbic Acid | 1 | 2004 | 120 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2005 | 409 | 0.010 |
Why?
| Hemostasis, Surgical | 1 | 2003 | 19 | 0.010 |
Why?
| Myelin Sheath | 1 | 2005 | 161 | 0.010 |
Why?
| Hepatocytes | 1 | 2004 | 213 | 0.010 |
Why?
| Colorado | 1 | 1992 | 4375 | 0.010 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2005 | 508 | 0.010 |
Why?
| Inactivation, Metabolic | 1 | 2002 | 11 | 0.010 |
Why?
| Enzyme Stability | 1 | 2002 | 67 | 0.010 |
Why?
| Cricetulus | 1 | 2002 | 104 | 0.010 |
Why?
| Pemetrexed | 1 | 2002 | 32 | 0.010 |
Why?
| Drug Contamination | 1 | 2002 | 50 | 0.010 |
Why?
| Citrate (si)-Synthase | 2 | 1993 | 58 | 0.010 |
Why?
| Brain Death | 1 | 2002 | 46 | 0.010 |
Why?
| Sex Characteristics | 1 | 2007 | 721 | 0.010 |
Why?
| Carcinoma | 1 | 2004 | 214 | 0.010 |
Why?
| Autoantibodies | 1 | 2010 | 1463 | 0.010 |
Why?
| Computational Biology | 1 | 2006 | 598 | 0.010 |
Why?
| Hepatomegaly | 1 | 2001 | 5 | 0.010 |
Why?
| Transcription Factors | 1 | 2010 | 1628 | 0.010 |
Why?
| Vasodilation | 1 | 2005 | 464 | 0.010 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2003 | 137 | 0.010 |
Why?
| Hypertension, Renal | 1 | 2001 | 16 | 0.010 |
Why?
| Radiography | 1 | 2004 | 859 | 0.010 |
Why?
| Treatment Refusal | 1 | 2002 | 87 | 0.010 |
Why?
| Kidney Transplantation | 1 | 2007 | 602 | 0.010 |
Why?
| Coffee | 1 | 2001 | 15 | 0.010 |
Why?
| Tea | 1 | 2001 | 20 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2003 | 751 | 0.010 |
Why?
| Chromatography, Gas | 1 | 2000 | 31 | 0.010 |
Why?
| Cell Survival | 1 | 2004 | 1077 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2005 | 1664 | 0.010 |
Why?
| Bone Marrow Diseases | 1 | 2000 | 19 | 0.010 |
Why?
| Platelet Count | 1 | 2000 | 82 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2000 | 108 | 0.010 |
Why?
| Disease Susceptibility | 1 | 2002 | 331 | 0.010 |
Why?
| Ultrasonography | 1 | 2004 | 710 | 0.010 |
Why?
| Liver Transplantation | 1 | 2007 | 798 | 0.010 |
Why?
| Kynurenine | 1 | 2000 | 105 | 0.010 |
Why?
| Probability | 1 | 2000 | 305 | 0.010 |
Why?
| Leukocyte Count | 1 | 2000 | 325 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2000 | 418 | 0.010 |
Why?
| Hypersplenism | 1 | 1999 | 7 | 0.010 |
Why?
| Rats, Wistar | 1 | 2000 | 397 | 0.010 |
Why?
| Tryptophan | 1 | 2000 | 169 | 0.010 |
Why?
| Zimbabwe | 1 | 1999 | 54 | 0.010 |
Why?
| Anemia, Aplastic | 1 | 1999 | 35 | 0.010 |
Why?
| Incidence | 1 | 2005 | 2616 | 0.010 |
Why?
| Life Style | 1 | 2001 | 460 | 0.010 |
Why?
| Viral Load | 1 | 2000 | 450 | 0.010 |
Why?
| Chromatography, DEAE-Cellulose | 2 | 1988 | 13 | 0.010 |
Why?
| Escherichia coli | 1 | 2002 | 765 | 0.010 |
Why?
| Carbon Radioisotopes | 2 | 1988 | 35 | 0.010 |
Why?
| Drug Overdose | 1 | 2002 | 319 | 0.010 |
Why?
| Indicators and Reagents | 2 | 1988 | 105 | 0.010 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2000 | 253 | 0.010 |
Why?
| Demyelinating Diseases | 1 | 1998 | 84 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2000 | 1009 | 0.010 |
Why?
| Antihypertensive Agents | 1 | 2001 | 485 | 0.010 |
Why?
| Leukemia | 1 | 1999 | 229 | 0.010 |
Why?
| Genes | 1 | 1996 | 226 | 0.010 |
Why?
| Deoxyuracil Nucleotides | 1 | 1996 | 3 | 0.010 |
Why?
| Theophylline | 1 | 1996 | 64 | 0.010 |
Why?
| Thymine Nucleotides | 1 | 1996 | 16 | 0.010 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 1996 | 50 | 0.010 |
Why?
| Wounds and Injuries | 1 | 2003 | 707 | 0.010 |
Why?
| Diet Surveys | 1 | 1996 | 92 | 0.010 |
Why?
| Swine, Miniature | 1 | 1996 | 79 | 0.010 |
Why?
| Acute Disease | 1 | 1999 | 964 | 0.010 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 1996 | 121 | 0.010 |
Why?
| Age of Onset | 1 | 1996 | 491 | 0.010 |
Why?
| Bronchodilator Agents | 1 | 1996 | 243 | 0.010 |
Why?
| Autopsy | 1 | 1994 | 92 | 0.010 |
Why?
| Radioimmunoassay | 1 | 1994 | 169 | 0.010 |
Why?
| Cell Division | 1 | 1996 | 778 | 0.010 |
Why?
| Chromatography | 1 | 1993 | 25 | 0.010 |
Why?
| Belgium | 1 | 1993 | 12 | 0.010 |
Why?
| Massachusetts | 1 | 1994 | 158 | 0.010 |
Why?
| Treatment Failure | 1 | 1995 | 339 | 0.010 |
Why?
| Netherlands | 1 | 1993 | 77 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2002 | 2264 | 0.010 |
Why?
| Germany | 1 | 1993 | 97 | 0.010 |
Why?
| Swine | 1 | 1996 | 742 | 0.010 |
Why?
| Stereoisomerism | 1 | 1993 | 92 | 0.010 |
Why?
| Blood Chemical Analysis | 1 | 1993 | 94 | 0.010 |
Why?
| Culture Media | 1 | 1993 | 164 | 0.010 |
Why?
| Borohydrides | 1 | 1991 | 1 | 0.010 |
Why?
| Mercaptoethanol | 1 | 1991 | 11 | 0.010 |
Why?
| Plasma | 1 | 1993 | 200 | 0.010 |
Why?
| Spectrum Analysis | 1 | 1991 | 86 | 0.010 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 1994 | 280 | 0.010 |
Why?
| Glutamate Dehydrogenase | 1 | 1990 | 3 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2002 | 2051 | 0.010 |
Why?
| Succinate Dehydrogenase | 1 | 1990 | 43 | 0.010 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 1990 | 45 | 0.010 |
Why?
| Molecular Structure | 1 | 1991 | 464 | 0.010 |
Why?
| Glucose | 1 | 1994 | 982 | 0.000 |
Why?
| Light | 1 | 1991 | 354 | 0.000 |
Why?
| Erythrocyte Indices | 1 | 1988 | 27 | 0.000 |
Why?
| Hypesthesia | 1 | 1988 | 16 | 0.000 |
Why?
| Ataxia | 1 | 1988 | 41 | 0.000 |
Why?
| Oxygen Consumption | 1 | 1990 | 669 | 0.000 |
Why?
| Intestines | 1 | 1990 | 344 | 0.000 |
Why?
| Algorithms | 1 | 1994 | 1618 | 0.000 |
Why?
| Celiac Disease | 1 | 1990 | 287 | 0.000 |
Why?
| Models, Theoretical | 1 | 1989 | 542 | 0.000 |
Why?
| Chemistry | 1 | 1985 | 42 | 0.000 |
Why?
| Chemical Phenomena | 1 | 1985 | 80 | 0.000 |
Why?
| Proteins | 1 | 1990 | 932 | 0.000 |
Why?
| Asthma | 1 | 1996 | 2213 | 0.000 |
Why?
|
|
Stabler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|